Michael King is Professor of Biomedical Engineering at Cornell. The King lab is currently testing novel cancer therapies in mouse models of metastatic breast and prostate cancer through the use of whole body luminescence imaging. This work will uncover new therapeutic targets designed to prevent metastasis.
Many colleges and universities have institutional memberships. If you are affiliated with a subscribing institution, please access Faculti through your on-campus or proxy IP address. Alternatively, as a Guest, you have insight(s) remaining for this month. Register for free and view more today.